GGrantIndex
Sort

16,300 grants matching fatty liver disease

Comparative Effectiveness of Two Initial Combination Therapies in Patients with New Onset Diabetes

$684,914
Muhammad Abdul-Ghani · University Of Texas Hlth Science Center · R01 · FY2024 · DK

Role of hypothalamic SH2B1 neurocircuits and SH2B1 signal transduction pathways in obesity and metabolic disease

$684,895
Liangyou Rui · University Of Michigan At Ann Arbor · R01 · FY2025 · DK

Mechanisms of Duox2 variants in the pathogenesis of preclinical IBD

$684,668
John Y Kao · University Of Michigan At Ann Arbor · R01 · FY2023 · DK

Mechanisms of Duox2 variants in the pathogenesis of preclinical IBD

$684,668
John Y Kao · University Of Michigan At Ann Arbor · R01 · FY2025 · DK

Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women

$684,441
Andrea A. Kovacs · University Of Southern California · R01 · FY2020 · DA

The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism

$684,436
Michael Karin · University Of California, San Diego · R01 · FY2023 · DK

HIV, HCV and the Menopausal Transition: Effects on Steatosis and Fibrosis Progression

$684,328
Phyllis C Tien · Northern California Institute/Res/Edu · R01 · FY2018 · DK

Dynamic Cardiac SPECT Imaging

$684,176
University Of Calif-Lawrenc Berkeley Lab · R01 · FY2004 · HL

Integrative Polygenic Genetic Studies of Non-alcoholic Fatty Liver Disease

$684,141
Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2022 · DK

Pathogenesis of youth onset pre-diabetes and Type 2 diabetes

$684,085
Sonia Caprio · Yale University · R01 · FY2025 · DK

Mechanisms of SGLT2 Inhibition in Pediatric NAFLD

$683,996
Justin R. Ryder · Lurie Children'S Hospital Of Chicago · R01 · FY2024 · DK

Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis

$683,885
Veronica Wendy Setiawan · University Of Southern California · R01 · FY2022 · MD

Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis

$683,885
Hugo R Rosen · University Of Southern California · R01 · FY2021 · MD

Molecular Regulation of Muscle Glucose Metabolism in Man

$683,776
Lawrence J Mandarino · University Of Arizona · R01 · FY2019 · DK

Molecular Regulation of Muscle Glucose Metabolism in Man

$683,776
Lawrence J Mandarino · University Of Arizona · R01 · FY2020 · DK

Exploring the Fuel-Mediated Programming of Neonatal Growth

$683,730
Dana Dabelea · University Of Colorado Denver · R01 · FY2015 · DK

HCC Risk Stratification in MAFLD Cirrhosis

$683,729
Hashem B El-Serag · Baylor College Of Medicine · P01 · FY2023 · CA

A Multi-Level Intervention to Promote Healthy Beverage Intake through Childcare

$683,700
Anisha Indravadan Patel · Stanford University · R01 · FY2021 · DK

Intersection of Exercise and Estrogen in Weight Regain After Weight Loss

$683,477
Paul S Maclean · University Of Colorado Denver · U54 · FY2023 · AG

Futuros Fuertes 2.0: A primary care-based intervention to prevent obesity in low-income Latino children

$683,456
Amy Laura Beck · University Of California, San Francisco · R01 · FY2024 · HD

Social determinants of fatty liver disease and its racial/ethnic disparities: The Multi-Ethnic Study of Atherosclerosis

$683,378
Mariana Lazo Elizondo · Drexel University · R01 · FY2023 · DK

Combating Chronic Liver Diseases via Understanding and Engineering Cell Competition and Fitness

$683,339
Michael Oertel · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK

Combating Chronic Liver Diseases via Understanding and Engineering Cell Competition and Fitness

$683,339
Michael Oertel · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK

Disease-modifying drugs for T2D through targeting the Unfolded Protein Response

$683,334
Feroz R Papa · University Of California, San Francisco · R01 · FY2024 · DK

Integrative Polygenic Genetic Studies of Non-alcoholic Fatty Liver Disease

$683,142
Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2023 · DK